Holen Sie sich die Stockscreener-App
0.3501
0.91%
-0.0032
Femasys Inc Aktie (FEMY) Neueste Nachrichten
Femasys Inc. Partners with Kebomed to Expand FemBloc Permanent Birth Control Availability in France and Benelux Region - Quiver Quantitative
Femasys announces partnership with Kebomend to commercialize FemBloc - TipRanks
First Non-Surgical Permanent Birth Control: Femasys' FemBloc Launches Major European Expansion - Stock Titan
Femasys partners with Medical Electronic Systems for FemSperm kit - Yahoo Finance
Femasys partners with MES to launch sperm analysis kit By Investing.com - Investing.com Nigeria
Comparing Femasys Inc. in custom built stock radarsMarket Growth Summary & Real-Time Sentiment Analysis - newser.com
Technical signs of recovery in Femasys Inc.July 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Femasys partners with MES to launch sperm analysis kit - Investing.com India
How to track smart money flows in Femasys Inc.2025 Market Outlook & Growth Focused Investment Plans - newser.com
Femasys Inc. recovery potential after sell offEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
Femasys Inc. Partners with Medical Electronic Systems to Launch FemSperm Analysis Kit, Enhancing In-Office Infertility Treatment - Quiver Quantitative
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed - GlobeNewswire
2X Higher Pregnancy Rates: Femasys Expands FemSperm Line for Revolutionary FemaSeed Fertility Treatment - Stock Titan
Critical Comparison: PDS Biotechnology (NASDAQ:PDSB) and Femasys (NASDAQ:FEMY) - Defense World
Market Pulse: Is Femasys Inc stock undervalued right nowEarnings Recap Summary & Daily Profit Focused Stock Screening - خودرو بانک
Setup Watch: Will Femasys Inc. benefit from current market trendsQuarterly Trade Report & Technical Confirmation Trade Alerts - خودرو بانک
Using flow based indicators on Femasys Inc.Earnings Summary Report & Community Driven Trade Alerts - newser.com
What MACD and RSI say about Femasys Inc.Earnings Trend Report & Real-Time Buy Signal Alerts - newser.com
Short interest data insights for Femasys Inc.Weekly Profit Analysis & Technical Confirmation Alerts - newser.com
Buy Signal: Can ARCT stock double in the next yearJuly 2025 Trade Ideas & Step-by-Step Swing Trade Plans - khodrobank.com
Market Outlook: Is Femasys Inc. a turnaround storyQuarterly Trade Review & Precise Entry and Exit Recommendations - khodrobank.com
Key metrics from Femasys Inc.’s quarterly dataMarket Performance Recap & Stock Portfolio Risk Management - newser.com
Is Femasys Inc benefiting from interest rate changesQuarterly Profit Review & Low Risk High Win Rate Picks - خودرو بانک
Femasys Inc. stock trend outlook and recovery path2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Can trapped investors hope for a rebound in Femasys Inc.Forecast Cut & Safe Capital Allocation Plans - newser.com
Options Flow: Is Femasys Inc stock undervalued right nowJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - خودرو بانک
Detecting support and resistance levels for Femasys Inc.Portfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
Femasys stock falls after pricing capital raise of $8M via securities offering - MSN
Volatility Watch: Is Femasys Inc a momentum stockJobs Report & Capital Efficient Trade Techniques - خودرو بانک
How institutional ownership impacts Femasys Inc. stockEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
Aug Setups: Can Femasys Inc. deliver consistent dividendsWeekly Profit Recap & Free Growth Oriented Trading Recommendations - khodrobank.com
Stock Market Recap: Is Femasys Inc. a potential multi baggerWeekly Investment Summary & Short-Term High Return Strategies - khodrobank.com
Will Femasys Inc. price bounce be sustainablePortfolio Growth Summary & High Conviction Buy Zone Picks - newser.com
Chart based exit strategy for Femasys Inc.2025 AllTime Highs & High Conviction Trade Alerts - newser.com
Femasys Attracts $8 Million in Funding - Medical Product Outsourcing
Femasys Inc. Expands FemSperm?? Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemSeed - MarketScreener
Femasys Inc. Launches FemSperm Insemination Prep Kit to Enhance Accessibility of Fertility Treatments - Quiver Quantitative
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed® - The Manila Times
Femasys expands FemSperm product line with Insemination Prep Kit - TipRanks
10M Women Could Benefit: Femasys Launches Game-Changing Fertility Kit for Gynecologist Offices - Stock Titan
Femasys Expands FemSperm™ Product Line with New - GlobeNewswire
Femasys Gains UK Approval for FemBloc Birth Control - MSN
Merger Talk: Is Femasys Inc. a turnaround storyJuly 2025 Fed Impact & Stock Market Timing Techniques - 뉴스영
Femasys Inc. Receives MEDSAFE Approval for FemBloc Permanent Birth Control in New Zealand, Expanding Global Access to Innovative Women's Health Solutions - Quiver Quantitative
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand - GlobeNewswire
2.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):